You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
Market News

Market News

HomeMarket NewsInformation about Individual Stocks

BeiGene, Ltd. (06160)

BeiGene, Ltd., through its subsidiaries, engages in the development and commercialization of oncology medicines worldwide.